Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company developing novel gene therapies for life-threatening rare genetic diseases. The Company’s lead programs include ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene ther... Read more
Yahoo
MarketWatch
MarketWatch
CNBC
Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.